Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2023 financial results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today.
Revenues declined 41% year-over-year to $14.2 billion, missing estimates.
The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat expectations.
Pfizer expects revenues of $58.5-61.5 billion for the full year of 2024. Adjusted EPS is expected to be $2.05-2.25.
The stock stayed in green during premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Everything you need to know about Medline’s IPO
After a modest start to the year, IPO activity rebounded in the second half of the year as recession fears eased and investor confidence increased. Medical supply company Medline Inc.
Chewy (CHWY): Three factors that work in favor of this pet retailer
Shares of Chewy, Inc. (NYSE: CHWY) gained over 1% on Monday. The stock has dropped 10% in the past three months. The pet products seller delivered solid results for the
Earnings Preview: Will cost pressures impact Darden Restaurants’ Q2 results?
Darden Restaurants, Inc. (NYSE: DRI), a full-service restaurant operator, has faced margin pressure this year from higher input costs tied to tariffs on key commodities. Despite that, management remains optimistic,
